Citadel Advisors’s NRC Health Common Stock NRC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
– Sell
-100
Closed -$1.76K – 15245
2024
Q4
$1.76K Sell
100
-200
-67% -$3.79K ﹤0.01% 14150
2024
Q3
$6.86K Sell
300
-100
-25% -$2.26K ﹤0.01% 13395
2024
Q2
$9.18K Buy
+400
New +$12.3K ﹤0.01% 13150

Other funds holding NRC

Citadel Advisors's NRC Position: Q2 2026 in Review

Citadel Advisors opened a new position in NRC Health Common Stock (NRC) in Q2 2026: 64,095 shares worth $1.38M. The stake represents ﹤0.01% of the portfolio and ranks #7412 among its holdings. This is a return to the name: Citadel Advisors previously reported a position in NRC as recently as Q4 2025.

Citadel Advisors first reported a position in NRC in Q1 2016 and has held it in 29 quarters since. The position peaked at $3.04M in Q2 2024. 123 funds tracked by Wall St. Rank hold NRC as of Q2 2026.

  • Citadel Advisors held 64,095 shares of NRC Health Common Stock worth $1.38M as of Q2 2026.
  • NRC Health Common Stock was a new Citadel Advisors position in Q2 2026.
  • NRC Health Common Stock made up ﹤0.01% of Citadel Advisors's portfolio in Q2 2026, its #7412 holding.
  • Citadel Advisors first reported a position in NRC Health Common Stock in Q1 2016 and has held it in 29 quarters since.
  • Citadel Advisors's NRC Health Common Stock position peaked at $3.04M in Q2 2024.
  • 123 funds tracked by Wall St. Rank held NRC Health Common Stock as of Q2 2026.

Based on Citadel Advisors's 13F filing for Q2 2026, filed 14 Aug 2026.